Searched for
ZUMUTOR BIOLOGICS FUNDING
Incubated at C-CAMP, seven deeptech startups have raised more than Rs 550 croreC-CAMP is one of the largest biotech ecosystems in India and a global hub for innovations led by deep-tech.
Flipkart's sweet Diwali; chatbot firms cheer 'WhatsApp commerce'The Flipkart Group, including fashion portal Myntra, bagged a market share of around 60% during this year's Diwali sales, according to data...
Zumutor Biologics bags $6.2 million funding led by Siana CapitalThe latest round also saw participation from existing investors Accel and Bharat Innovation Fund, bringing the total capital raised by the ...
This firm is hunting for a cancer cureZumutor, the Boston-headquartered startup, which was founded by second-time entrepreneur and former Biocon executive Kavitha Iyer Rodrigues...
Zumutor Biologics gets $4 million in fresh fundsThe company said the capital will be used for the process of new drug filing of its lead molecule (ZM 008) in India, and to go through the ...
ET Startup Awards: Nominees for the 'Top Innovator' categoryThe shortlisted startups carry unique ideas providing solutions to various existing problems.
Rajat taught me to stay right: K Chandrasekhar, CEO, Forus HealthWHAT I LEARNT FROM MY MENTOR: In the run-up to the grand finale of the ET Startup Awards 2017, your favourite paper presents a special seri...
ET Startup Awards 2017: ET-Facebook woman ahead award goes to Falguni Nayar of NykaaAn IIM- Ahmedabad alumna, Nayar founded Nykaa in 2012 after quitting as MD of Kotak Mahindra Capital Company, where she had spent 18 years.
ET Startup Awards: Meet the women who brought in a changeThis is what the jurists are looking for to be the chosen ones for The Economic Times Startup Awards.
India's biotech capital spreads its wingsConsidering the state of the industry, and the presence of so many academic institutions in Bengaluru, seasoned entrepreneurs think that th...
Zumutor Biologics partners with Catalent; complete study that may help cancer treatmentZumutor is in pre-phase one stage of developing a new version of a bestselling breast cancer drug with 20-fold functionality enhancement.